Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO).

MLA

Lai, Yu-Ting, et al. “Benefit of Dual Bronchodilator Therapy on Exacerbations in Former and Current Smokers with Chronic Obstructive Pulmonary Disease in Real-World Clinical Practice: A Multicenter Validation Study (TOReTO).” Respiratory Research, vol. 25, no. 1, Oct. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12931-024-02971-3.

APA

Lai, Y.-T., Tsai, Y.-H., Hsieh, M.-J., Chen, N.-H., Cheng, S.-L., Tao, C.-W., Wei, Y.-F., Wu, Y.-K., Chan, M.-C., Liu, S.-F., Hsu, W.-H., Yang, T.-M., Liu, C.-L., Kuo, P.-H., & Lin, M.-S. (2024). Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO). Respiratory Research, 25(1), 1–11. https://doi.org/10.1186/s12931-024-02971-3

Chicago

Lai, Yu-Ting, Ying-Huang Tsai, Meng-Jer Hsieh, Ning-Hung Chen, Shih-Lung Cheng, Chi-Wei Tao, Yu-Feng Wei, et al. 2024. “Benefit of Dual Bronchodilator Therapy on Exacerbations in Former and Current Smokers with Chronic Obstructive Pulmonary Disease in Real-World Clinical Practice: A Multicenter Validation Study (TOReTO).” Respiratory Research 25 (1): 1–11. doi:10.1186/s12931-024-02971-3.